R. Kent McGaughy Jr., Director, 10% Owner at REATA PHARMACEUTICALS INC (RETA), bought 28,440 shares at $17.62 ($500K) on 2016-06-07, disclosed to the SEC on 2016-06-08.
Open-market purchase of $500k RETA by Director, 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $17.56 | 20,000 | $351K | 70.3% |
| 2 | $17.62 | 4,220 | $74K | 14.9% |
| 3 | $17.62 | 4,220 | $74K | 14.9% |
| Total | $17.58 avg | 28,440 | $500K | 100% |
| Filing → |
| TIL | BUY | 2021-03-25 | $9.0M | — | Filing → |
| APEN | BUY | 2020-07-21 | $2.2M | — | Filing → |
| RETA | BUY | 2019-11-18 | $7.4M | — | Filing → |